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retrospectively. Forty of the 107 patients agreed to participate and were enrolled in the exercise group, while 35 patients acted as controls. Of the 40 patients in the exercise group, 16 (40%) were excluded from the analysis as they did not complete 6 months of exercise. Three patients from the control group were also excluded due to death (1), transplant renal artery stenosis requiring nephrectomy (1) and transplant rejection requiring nephrectomy (1). In the exercise group, the mean age was 52.8 (+/-16.0) years and 58.3% of the patients were women. In the control group, the mean age was 56.1 (+/-15.2) years and 56.3% were women.
Study design
This was a prospective cohort study that was carried out in a single centre. The patients were followed up for 6 months. As already stated, 16 (40%) patients in the exercise group were lost to follow-up due to death (2), cocaine use requiring rehabilitation (2), kidney transplantation (2) and voluntary withdrawal (10). The attending nephrologists were not blinded to the participants because the exercise occurred in the dialysis unit.
Analysis of effectiveness
All of the patients included in the study were accounted for in the analysis. The primary health outcomes were blood pressure and antihypertensive use. All blood pressure measurements were taken from the patient's flow sheets before and after each dialysis session. Systolic and diastolic blood pressure measurements were made in the arm while sitting, immediately before and after the haemodialysis session. Two investigators reviewed blood pressure medications with the patients at the start of the study and at month 6. These correlated with the medical record. No formal measure of compliance was performed. The groups were shown to be comparable at analysis in terms of their age, gender and prognostic features.
Effectiveness results
No significant difference in blood pressure was observed at 6 months, (p=0.12), but at 3 months the predialysis blood pressure and postdialysis systolic pressure were significantly lower in the exercise group.
Changes in the usage of blood pressure medication at 6 months resulted in statistically significant dosage decreases among the exercise patients, compared with the control patients. The mean number of antihypertensive medications per patient before the study was 2.13 in the exercise group and 1.91 in the control group. At the end of the 6-month study, this had fallen to 1.5 in the exercise group, but remained at 1.91 in the control group. Thus, exercise resulted in an average relative benefit of -0.71 medications per patient, or a 36% reduction in medication use at 6 months, (p=0.018).
Clinical conclusions
Exercise during haemodialysis produced a significant reduction in blood pressure medication use. However, despite this decrease in medication, no change in actual blood pressure was seen at 6 months.
Measure of benefits used in the economic analysis
No summary benefit measure was used in the economic analysis. In effect, a cost-consequences approach was adopted.
Direct costs
The resource quantities and the costs were not reported separately. The direct costs in the analysis were those of the PBM company, including their pharmaceutical acquisition costs. It was assumed that the lowest priced generic substitute would be used when such a generic was available. Discounting was irrelevant, as all the costs were incurred in a 6-month period, and was not conducted. The price data referred to 2000.
Statistical analysis of costs
The costs were treated stochastically. The authors used a two-tailed Student's t-test, with significance set at the 0.05 level.
